• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

经静脉植入式心律转复除颤器的导线故障：有效管理的新契机。

Lead failure in transvenous implantable cardioverter defibrillator: a new opportunity for an effective management.

作者信息

Pignalberi Carlo, Colivicchi Furio

机构信息

Cardiology Division "San Filippo Neri" Hospital Rome Italy.

出版信息

Clin Case Rep. 2018 Jul 7;6(9):1668-1670. doi: 10.1002/ccr3.1533. eCollection 2018 Sep.

DOI:10.1002/ccr3.1533
PMID:30214738
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6132094/
Abstract

In case of transvenous defibrillator lead failure, a subcutaneous defibrillator may be implanted and the lead may be abandoned in order to avoid particular risk situations. For patients who require pacing and with an operational atrial lead, the transvenous ICD may be also maintained to ensure antibradycardia support.

摘要

在经静脉除颤器导线出现故障的情况下，可以植入皮下除颤器，并可舍弃该导线，以避免特殊的风险情况。对于需要起搏且心房导线仍在正常工作的患者，也可保留经静脉植入式心律转复除颤器，以确保抗心动过缓支持。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96a0/6132094/f29b4893afa5/CCR3-6-1668-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96a0/6132094/ca12793211a4/CCR3-6-1668-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96a0/6132094/f29b4893afa5/CCR3-6-1668-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96a0/6132094/ca12793211a4/CCR3-6-1668-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96a0/6132094/f29b4893afa5/CCR3-6-1668-g002.jpg

相似文献

1
Lead failure in transvenous implantable cardioverter defibrillator: a new opportunity for an effective management.经静脉植入式心律转复除颤器的导线故障：有效管理的新契机。
Clin Case Rep. 2018 Jul 7;6(9):1668-1670. doi: 10.1002/ccr3.1533. eCollection 2018 Sep.
2
Shock Without Wires: A Look at Subcutaneous Implantable Cardioverter-Defibrillator Compared to Transvenous Implantable Cardioverter-Defibrillator for Ventricular Arrhythmias.无导线除颤器：皮下植入式除颤器与经静脉植入式除颤器治疗室性心律失常的比较。
Curr Probl Cardiol. 2022 Sep;47(9):100927. doi: 10.1016/j.cpcardiol.2021.100927. Epub 2021 Jul 3.
3
Implantable transvenous cardioverter-defibrillators.植入式经静脉心脏复律除颤器
Circulation. 1993 Apr;87(4):1152-68. doi: 10.1161/01.cir.87.4.1152.
4
[Transvenous subcutaneous implantation technique of the cardioverter/defibrillator].[心脏复律除颤器的经静脉皮下植入技术]
Herz. 1994 Oct;19(5):259-77.
5
Subcutaneous implantable cardioverter defibrillator indication in prevention of sudden cardiac death in difficult clinical situations: A French expert position paper.皮下植入式心律转复除颤器在困难临床情况下预防心源性猝死的适应证：法国专家立场文件。
Arch Cardiovasc Dis. 2020 May;113(5):359-366. doi: 10.1016/j.acvd.2020.03.011. Epub 2020 Apr 22.
6
Lead fracture in cephalic versus subclavian approach with transvenous implantable cardioverter defibrillator systems.经静脉植入式心律转复除颤器系统头静脉与锁骨下静脉途径的导线断裂情况
Pacing Clin Electrophysiol. 1996 Jul;19(7):1089-94. doi: 10.1111/j.1540-8159.1996.tb03418.x.
7
Subcutaneous Versus Transvenous Implantable Defibrillator Therapy: A Meta-Analysis of Case-Control Studies.皮下与经静脉植入式心脏除颤器治疗：病例对照研究的荟萃分析。
JACC Clin Electrophysiol. 2017 Dec 26;3(13):1475-1483. doi: 10.1016/j.jacep.2017.07.017. Epub 2017 Sep 27.
8
Efficacy and Complications of Subcutaneous versus Conventional Cardioverter Defibrillators: A Systematic Review and Meta-analysis.皮下与传统心脏除颤器的疗效和并发症：系统评价和荟萃分析。
Curr Cardiol Rev. 2022;18(3):e081221198647. doi: 10.2174/1573403X17666211208100151.
9
Lead Macrodislodgement of a Subcutaneous Implantable Cardioverter-Defibrillator Results in a Reel Problem.皮下植入式心脏复律除颤器的导线大移位导致卷轴问题。
JACC Case Rep. 2021 Mar 17;3(3):523-527. doi: 10.1016/j.jaccas.2021.01.024. eCollection 2021 Mar.
10
State-of-the-art consensus on non-transvenous implantable cardioverter-defibrillator therapy.非经静脉植入式心律转复除颤器治疗的最新共识。
Clin Cardiol. 2020 Oct;43(10):1084-1092. doi: 10.1002/clc.23432. Epub 2020 Aug 14.

本文引用的文献

1
Specific indications and clinical outcome in patients with subcutaneous implantable cardioverter-defibrillator (ICD) - A nationwide multicentre registry.皮下植入式心律转复除颤器（ICD）患者的具体适应证和临床结局-全国多中心注册研究。
Eur J Intern Med. 2018 Feb;48:64-68. doi: 10.1016/j.ejim.2017.09.038. Epub 2017 Oct 1.
2
Implant and Midterm Outcomes of the Subcutaneous Implantable Cardioverter-Defibrillator Registry: The EFFORTLESS Study.皮下植入式心脏复律除颤器注册研究的植入和中期结果：EFFORTLESS 研究。
J Am Coll Cardiol. 2017 Aug 15;70(7):830-841. doi: 10.1016/j.jacc.2017.06.040.
3
Combination of a leadless pacemaker and subcutaneous defibrillator: First in-human report.
无导线起搏器与皮下除颤器联合应用：首例人体报告。
HeartRhythm Case Rep. 2015 Jul 30;1(6):469-471. doi: 10.1016/j.hrcr.2015.07.009. eCollection 2015 Nov.
4
Epicardial CRT-P- and S-ICD Implantation in a Young Patient with Persistent Left Superior Vena Cava.一名患有永存左上腔静脉的年轻患者的心外膜CRT-P和S-ICD植入术
Herzschrittmacherther Elektrophysiol. 2016 Dec;27(4):396-398. doi: 10.1007/s00399-016-0451-5. Epub 2016 Sep 19.
5
Implantable Cardiac Defibrillator Lead Failure and Management.植入式心脏除颤器导线故障与管理。
J Am Coll Cardiol. 2016 Mar 22;67(11):1358-68. doi: 10.1016/j.jacc.2015.12.067.
6
Prevalence and predictor factors of severe venous obstruction after cardiovascular electronic device implantation.心血管电子设备植入术后重度静脉阻塞的患病率及预测因素。
Europace. 2016 Aug;18(8):1220-6. doi: 10.1093/europace/euv391. Epub 2015 Dec 24.
7
Clinical experience of subcutaneous and transvenous implantable cardioverter defibrillators in children and teenagers.儿童和青少年皮下及经静脉植入式心律转复除颤器的临床经验。
Pacing Clin Electrophysiol. 2013 Dec;36(12):1532-8. doi: 10.1111/pace.12233. Epub 2013 Sep 13.